Genotypic resistance in HIV-Infected naive patients receiving abacavir plus lamivudine and efavirenz

被引：1
|
作者：
Ferrer, Elena [1 ]
Niubo, Jordi
Crespo, Manuel
Gatell, Josep Maria
Sanz, Jose
Veloso, Sergio
Llibre, Josep Maria
Barrufet, Pilar
Sanchez, Pochita
Podzamczer, Daniel
机构：
[1] Hosp Univ Bellvitge, Barcelona, Spain
[2] Hosp Gen Valle Hebron, Barcelona, Spain
[3] Hosp Clin Barcelona, Barcelona, Spain
[4] Hosp Principe Asturias, Alcala De Henares, Spain
[5] Hosp Joan 23, Tarragona, Spain
[6] Hosp Calella, Barcelona, Spain
[7] Hosp Mataro, Barcelona, Spain
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2007年 / 46卷 / 02期
关键词：
D O I：
10.1097/QAI.0b013e318074efd1
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：253 / 255
页数：3
相关论文
共 50 条
  • [41] Emergence of zidovudine resistance in HIV-Infected patients receiving stavudine
    de Mendoza, C
    Soriano, V
    Briones, C
    Gallego, O
    Barreiro, P
    Alvarez, A
    González-Lahoz, J
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (03) : 279 - 281
  • [42] Real-world efficacy and safety of dolutegravir plus lamivudine versus tenofovir plus lamivudine and efavirenz in ART-naive HIV-1-infected adults
    Li, Jin
    Chen, Dabiao
    Wen, Zhiwei
    Du, Yanzhang
    Huang, Zhanlian
    Zhong, Huijun
    Wang, Yanhao
    Yin, Sichun
    MEDICINE, 2022, 101 (42) : E31100
  • [43] Reasons for early abacavir discontinuation in HIV-infected patients
    Peyriere, H
    Guillemin, V
    Lotthe, A
    Baillat, V
    Fabre, J
    Favier, C
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (10) : 1392 - 1397
  • [44] Minimum effective plasma concentration of efavirenz in treatment-naive Chinese HIV-infected patients
    Sun, J.
    Chen, J.
    Yao, Y.
    Zhang, R.
    Zheng, Y.
    Liu, L.
    Zhang, L.
    Shen, Y.
    Lu, H.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2010, 21 (12) : 810 - 813
  • [45] Effectiveness and tolerability of abacavir-lamivudine-nevirapine (ABC/3TC/NVP) in a multicentre cohort of HIV-infected, ARV-naive patients
    Podzamczer, Daniel
    Fredy Rojas, Jhon
    Neves, Isabel
    Ferrer, Elena
    Llibre, Josep M.
    Leal, Manuel
    Gorgolas, Miguel
    Jose Crusells, Ma
    Gatell, Josep Ma
    Correia Abreu, Ricardo
    Curto, Jordi
    Domingo, Pere
    Pilar Barrufet, Ma
    Rozas, Nerea
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 172 - 172
  • [46] Pharmacokinetics and pharmaco dynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir
    Millán, O
    Brunet, M
    Martorell, J
    García, F
    Vidal, E
    Rojo, I
    Plana, M
    Gallart, T
    Pumarola, T
    Miró, JM
    Gatell, JM
    CLINICAL PHARMACOKINETICS, 2005, 44 (05) : 525 - 538
  • [47] Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
    Palacios, R.
    Perez-Hernandez, I. A.
    Martinez, M. A.
    Mayorga, M. L.
    Gonzalez-Domenech, C. M.
    Omar, M.
    Olalla, J.
    Romero, A.
    Romero, J. M.
    Perez-Camacho, I.
    Hernandez-Quero, J.
    Santos, J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2016, 35 (05) : 815 - 819
  • [48] Efficacy and safety of switching to abacavir/lamivudine (ABC/3TC) plus rilpivirine (RPV) in virologically suppressed HIV-infected patients on HAART
    R. Palacios
    I. A. Pérez-Hernández
    M. A. Martínez
    M. L. Mayorga
    C. M. González-Domenech
    M. Omar
    J. Olalla
    A. Romero
    J. M. Romero
    I. Pérez-Camacho
    J. Hernández-Quero
    J. Santos
    European Journal of Clinical Microbiology & Infectious Diseases, 2016, 35 : 815 - 819
  • [49] Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain
    Gomez-Cano, M
    Rubio, A
    Puig, T
    Perez-Olmeda, M
    Ruiz, L
    Soriano, V
    Pineda, JA
    Zamora, L
    Xaus, N
    Clotet, E
    Leal, M
    AIDS, 1998, 12 (09) : 1015 - 1020
  • [50] Efficacy of pegylated interferon plus ribavirin treatment in HIV/hepatitis C virus co-infected patients receiving abacavir plus lamivudine or tenofovir plus either lamivudine or emtricitabine as nucleoside analogue backbone
    Mira, Jose A.
    Lopez-Cortes, Luis F.
    Barreiro, Pablo
    Tural, Cristina
    Torres-Tortosa, Manuel
    de los Santos Gil, Ignacio
    Martin-Rico, Patricia
    Rios-Villegas, Maria J.
    Juan Hernandez-Burruezo, Jose
    Merino, Dolores
    Angel Lopez-Ruz, Miguel
    Rivero, Antonio
    Munoz, Leopoldo
    Gonzalez-Serrano, Mercedes
    Collado, Antonio
    Macias, Juan
    Viciana, Pompeyo
    Soriano, Vincent
    Pineda, Juan A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1365 - 1373
12345